 Sorrento Therapeutics Inc NASDAQ: SRNE has released new data on STI-9167, an advanced stage antibody against COVID-19. The antibody was discovered and developed in an ongoing collaboration between Sorrento and the Icahn School of Medicine at Mount Sinai. 